IDYA IDEAYA Biosciences Inc
Price (delayed)
$16.35
Market cap
$1.43B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.36
Enterprise value
$1.37B
IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates
Highlights
The revenue has surged by 78% since the previous quarter but it has dropped by 70% year-on-year
The company's gross profit has surged by 78% QoQ but it has shrunk by 70% YoY
The net income has plunged by 143% YoY and by 54% from the previous quarter
The EPS has dropped by 71% year-on-year and by 44% since the previous quarter
Key stats
What are the main financial stats of IDYA
Market
Valuations
Earnings
Shares outstanding
87.54M
Market cap
$1.43B
Enterprise value
$1.37B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.33
Price to sales (P/S)
190.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
195.03
Revenue
$7M
Gross profit
$7M
Operating income
-$326.98M
Net income
-$274.48M
EBIT
-$274.48M
EBITDA
-$270.64M
Free cash flow
-$251.44M
Per share
Balance sheet
Liquidity
EPS
-$3.36
EPS diluted
-$3.36
Free cash flow per share
-$3.08
Book value per share
$12.25
Revenue per share
$0.09
TBVPS
$13.76
Total assets
$1.12B
Total liabilities
$64.94M
Debt
$19.17M
Equity
$1.06B
Working capital
$643.64M
Debt to equity
0.02
Current ratio
14.97
Quick ratio
14.7
Net debt/EBITDA
0.24
Margins
Efficiency
Dividend
EBITDA margin
-3,866.3%
Gross margin
100%
Net margin
-3,921.1%
Operating margin
-4,671.1%
Return on assets
-25.5%
Return on equity
-26.7%
Return on invested capital
-32.2%
Return on capital employed
-25.5%
Return on sales
-3,921.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDYA stock price
How has the IDEAYA Biosciences stock price performed over time
Intraday
10.7%
1 week
-6.25%
1 month
-20.52%
1 year
-60.6%
YTD
-36.38%
QTD
-0.18%
Financial performance
How have IDEAYA Biosciences's revenue and profit performed over time
Revenue
$7M
Gross profit
$7M
Operating income
-$326.98M
Net income
-$274.48M
Gross margin
100%
Net margin
-3,921.1%
The net income has plunged by 143% YoY and by 54% from the previous quarter
IDYA's operating income has dropped by 143% year-on-year and by 45% since the previous quarter
The revenue has surged by 78% since the previous quarter but it has dropped by 70% year-on-year
The company's gross profit has surged by 78% QoQ but it has shrunk by 70% YoY
Growth
What is IDEAYA Biosciences's growth rate over time
Valuation
What is IDEAYA Biosciences stock price valuation
P/E
N/A
P/B
1.33
P/S
190.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
195.03
The EPS has dropped by 71% year-on-year and by 44% since the previous quarter
IDEAYA Biosciences's equity has surged by 71% YoY but it has decreased by 10% QoQ
The stock's P/B is 55% below its last 4 quarters average of 2.7 and 52% below its 5-year quarterly average of 2.5
The revenue has surged by 78% since the previous quarter but it has dropped by 70% year-on-year
The stock's price to sales (P/S) is 67% more than its 5-year quarterly average of 103.2 but 52% less than its last 4 quarters average of 359.4
Efficiency
How efficient is IDEAYA Biosciences business performance
The company's return on equity fell by 38% QoQ and by 16% YoY
The ROA has contracted by 37% from the previous quarter and by 17% YoY
IDYA's ROIC is down by 29% from the previous quarter and by 7% YoY
The return on sales is up by 14% since the previous quarter
Dividends
What is IDYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDYA.
Financial health
How did IDEAYA Biosciences financials performed over time
IDEAYA Biosciences's total liabilities has soared by 130% YoY and by 9% from the previous quarter
IDEAYA Biosciences's total assets has surged by 73% YoY but it has decreased by 9% QoQ
The company's debt is 98% lower than its equity
IDEAYA Biosciences's equity has surged by 71% YoY but it has decreased by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.